Building Trust Through Quality and Integrity
Oncology for India and the World
Pavyoma Therapeutics is a Hyderabad-based pharmaceutical company on a mission to make high-quality oncology medicines more accessible.
Our Mission
Address critical gaps in cancer-medicine supply and make sure patients have access to the treatments they need. We develop, register and market oncology medicines with the aim to make cancer treatment affordable and available, first in India and then worldwide.
Our Vision
To be a trusted, patient-first oncology brand, recognised for quality, reliability and scientific integrity in every market we serve. We aspire to be the partner of choice for hospitals, oncologists and patients seeking dependable cancer care solutions.
Our Story
Founded by Ranipavithra (Rani) Sabhavat, Pavyoma Therapeutics brings together 20+ years of pharmaceutical experience across Australia, the United States and global markets. Our founder's deep expertise spans the full lifecycle: R&D, technology transfer, manufacturing, quality assurance, regulatory approvals and audits.
We recognized a critical need: high-quality oncology medicines that combine international standards with Indian affordability. Many cancer patients face supply gaps, inconsistent quality, or prohibitive costs. Pavyoma was created to solve this problem.
Starting with a focused portfolio of sterile injectables and oral oncology products, we are building the Pavyoma brand under our own name in India, with a clear path to regulated international markets including the USA, Europe, Australia, Mexico, the UAE and Asia.
Meet Our Founders
Experience and expertise that spans continents, bringing international pharmaceutical standards to oncology care.
Rani
Founder & Managing Director
Pharmaceutical professional with experience across Australia, the USA and global markets, covering the full lifecycle: R&D, technology transfer, manufacturing, quality assurance, regulatory approvals, audits and commercial supply.
Areas of Expertise
Avik
Co-Founder, Finance & Executive Director
Leads finance, investment and executive operations, including project funding and banking partnerships.
Areas of Expertise
The People Behind Pavyoma
A dedicated core team driving quality, operations and growth across every function.
Kishore
Business & Technical Operations
Drives business development and technical operations for the company.
Rakesh
Quality Operations & Market Complaint Management
Oversees quality operations and handling of market complaints.
Sandeep
Admin & Procurement
Manages administration, purchasing and vendor coordination.
Hemanth
IT Specialist
Manages IT systems and digital infrastructure.
How We're Building Pavyoma
A clear, focused strategy: start with excellence, build trust, scale with integrity.
Start Focused
Launch with a focused oncology injectable portfolio: Cisplatin, Carboplatin, Oxaliplatin and Etoposide — essential medicines for Indian hospitals and oncology centres.
Build the Brand
Establish Pavyoma as a trusted name in Indian oncology through quality, reliability and patient-first service. Build strong relationships with oncologists, hospitals and distributors.
Scale Globally
Expand into regulated international markets with ANDA/NDA filings for USA FDA, registrations in Europe (EMA), Australia (TGA), Mexico (COFEPRIS), UAE/GCC and Asian countries.
Building Pavyoma, Step by Step
From inception to international expansion — our roadmap to success.
Pavyoma Therapeutics Incorporated
Pavyoma Therapeutics Private Limited incorporated in Hyderabad, Telangana. Pavyoma Therapeutics Pty Ltd registered in Australia.
Core Team Assembled & Portfolio Defined
Core team formed across finance, quality, business development, administration and IT. Oncology portfolio defined with WHO certified products and brand launch planned for India.
Campus Planning & Regulatory Preparation
Detailed Project Report prepared for integrated, solar-powered manufacturing campus in Telangana. Regulatory dossiers prepared for international filings.
India Launch: Priority Injectables
Launch of cytotoxic injectables (Cisplatin, Carboplatin, Oxaliplatin, Etoposide) in India through distributor and hospital partnerships.
International Expansion & Own Manufacturing
ANDA/NDA filings for USA, registrations in Australia, Mexico, Europe, UAE and Asia. Commissioning of own integrated API, injectable and oral manufacturing campus.
What Sets Pavyoma Apart
Built on a foundation of quality, integrity and patient-first thinking.
Oncology-Only Focus
One therapy area, deep expertise, and patient-first thinking in every product we develop.
International Quality
WHO certified products in hand, with ANDA/NDA filings planned for USA FDA, Europe, Australia and more.
Affordable Access
High-quality cancer medicines at Indian affordability, closing supply gaps for hospitals and patients.
Founder-Led Agility
Lean, fast and responsive. A founder-led team that partners closely with hospitals and distributors.
Global Standards
20+ years of international pharmaceutical experience across Australia, USA and global markets.
Sustainable Future
Planned integrated, solar-powered, zero-liquid-discharge manufacturing campus in Telangana.
Certifications & Registrations
Our commitment to quality is backed by rigorous certifications and regulatory compliance.
WHO Certified Products (WHO-GMP)
Available
GST Registration
36AARCP2459C1Z8
Udyam / MSME Registration
UDYAM-TS-02-0354028
Drug Licences (CDSCO / Telangana DCA)
Available
US FDA, EMA, TGA, COFEPRIS
Planned / In Progress
Ready to Partner with Pavyoma?
Whether you're a distributor, hospital partner, or international importer, we'd love to discuss how we can work together.
Partner with us to bring affordable cancer treatment to patients worldwide.
Founded on 20+ years of global pharmaceutical experience, we combine international quality standards with Indian affordability. Our WHO certified oncology products are designed to close supply gaps and ensure patients have access to the treatments they need.